Table 3.
Synthetic polymers | Encapsulated drug/model compounds | Target treatment or effect | Particle size | Ref. |
---|---|---|---|---|
Biodegradable | ||||
PLGA | Hinokitol, 6-benzyaminopurin | Hair growth | 182–210 nm | 51 |
PLGA | indomethacin | Analgesic for transdermal delivery | 100 nm | 52 |
PLGA-chitosan | spantide II and ketoprofen | Anti-inflammatory | 169 nm | 53 |
Poly(ε-caprolactone) | Octyl methoxycinnamate | Sunscreen effect | 255–427 nm | 54 |
Poly(ε-caprolactone)-block-PEG | minoxidil | Anti-hairloss | 40 &130 nm | 55 |
Non-biodegradable | ||||
Polystyrene | Nile red | Hydrophobic dye (to study release mechanism) | 28–31 nm | 7 |
Poly(methyl methacrylate) | Nile red | Hydrophobic dye (to study release mechanism) | 68–100 nm | 56 |
Polyacrylate | N-thiolated β-lactam | Antibiotic for wound healing | 40 nm | 57 |